Parameter | Cases (n = 21) | Controls (n = 21) | p-value |
---|---|---|---|
P. aeruginosa infection; % (n) | 42.9 (9) | 52.4 (11) | 0.758 |
MDR P. aeruginosa colonization; % (n) | 100% (21) | 42.9 (9) | <0.001 |
SAPS II total (95%Confidence Interval [CI]) | 50 (37–59) | 44 (31–50) | 0.147 |
Colonization site; % (n) | |||
Tracheobronchial secretion | 42.9 (9) | 57.1 (12) | |
Intraabdominal swab | 9.5(2) | 9.5 (2) | |
Rectal | 28.6 (6) | - | |
Wound swab | 9.5 (2) | - | |
Urine | 38.1 (8) | 28.6 (6) | |
Blood | - | 4.8 (1) | |
Stay in a room with colonized sink; % (n) | 66.7 (14) | 28.6 (6) | 0.062a |
Contact with MDR colonized patient; % (n) | 14.3 (3) | - | |
All drainages; % (n) | 42.9 (9) | 61.9 (13) | 0.751 |
Dialysis or hemofiltration | 33.3 (7) | 4.8 (1) | 0.045a |
Gastric tube | 95.2 (20) | 85.7 (18) | 0.606 |
Urinary catheter | 100.0 (21) | 100.0 (21) | 1.000 |
Tracheal cannula | 38.1 (8) | 33.3 (7) | 1.000 |
Central venous catheter | 90.5 (19) | 85.7 (18) | 1.000 |
Leukopenia | 14.3 (3) | 14.3 (3) | 1.000 |
Immunosuppression | 38.1 (8) | 9.5 (2) | 0.067a |
Septic chock | 19.0 (4) | 28.6 (6) | 0.719 |
Surgery patient | 85.7 (18) | 90.5 (19) | 1.000 |
Neurosurgery patient | 14.3 (3) | 23.8 (5) | 0.697 |
Age (years) | 71.0 (55.2–78.1) | 75.5 (63.4–83.4) | 0.120 |
LOS before colonization (days) | 16 (11–34) | 10 (5–28) | 0.190 |
Length of stay overall (days) | 38 (23–54) | 30 (10–46) | 0.170 |
Stay in single room (days) | 0 (0–5) | 0 (0–9) | 1.000 |
Stay in shared room (days) | 12 (6–30) | 4 (0–16) | 0.031a |
Penicillin; % (n) | 42.9 (9) | 23.8 (5) | 0.362 |
Cephalosporin; % (n) | 42.9 (9) | 23.8 (5) | 0.362 |
Carbapenem; % (n) | 42.9 (9) | 28.6 (6) | 0.520 |
Quinolone; % (n) | 52.4 (11) | 23.8 (5) | 0.111 |
Aminoglycoside; % (n) | 28.6 (6) | 4.8 (1) | 0.093a |
Glycopeptide; % (n) | 28.6 (6) | 19.0 (4) | 0.719 |
Antibiotic inhalation; % (n) | 33.3 (7) | 9.5 (2) | 0.130 |